Natural Immunomodulators 2018

Affiliations

¹ Instituto de Investigación en Ciencias Biomédicas (IICB), CUCS, Universidad de Guadalajara, Guadalajara, JAL, Mexico.
² National Botanical Research Institute, Lucknow, Uttar Pradesh, India.
³ Witten/Herdecke University, Witten, Germany.

Editorial

Daniel Ortuño-Sahagún et al. J Immunol Res. 2019.

. 2019 Nov 3:2019:4341698.

doi: 10.1155/2019/4341698. eCollection 2019.

¹ Instituto de Investigación en Ciencias Biomédicas (IICB), CUCS, Universidad de Guadalajara, Guadalajara, JAL, Mexico.
² National Botanical Research Institute, Lucknow, Uttar Pradesh, India.
³ Witten/Herdecke University, Witten, Germany.

No abstract available

Conflict of interest statement

The editors declare that they have no conflicts of interest regarding the publication of this special issue.

1. Ortuño-Sahagún D., Zänker K., Rawat A. K. S., Kaveri S. V., Hegde P. Natural Immunomodulators. Journal of Immunology Research. 2017;2017:2. doi: 10.1155/2017/7529408.7529408 - DOI - PMC - PubMed
1. Jantan I., Ahmad W., Bukhari S. N. A. Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials. Frontiers in Plant Science. 2015;6:p. 655. doi: 10.3389/fpls.2015.00655. - DOI - PMC - PubMed
1. Chaplin D. D. Overview of the immune response. The Journal of Allergy and Clinical Immunology. 2010;125(2):S3–23. doi: 10.1016/j.jaci.2009.12.980. - DOI - PMC - PubMed
1. Hartung T., Corsini E. Immunotoxicology: challenges in the 21st century and in vitro opportunities. ALTEX. 2013;30(4):411–426. doi: 10.14573/altex.2013.4.411. - DOI - PubMed
1. Brennan F. R., Cauvin A., Tibbitts J., Wolfreys A. Optimized nonclinical safety assessment strategies supporting clinical development of therapeutic monoclonal antibodies targeting inflammatory diseases. Drug Development Research. 2014;75(3):115–161. doi: 10.1002/ddr.21173. - DOI - PubMed